Is Immune Checkpoint Inhibitor Treatment an Option for Patients With Rheumatic Diseases and Cancer?
Arthritis Rheumatol
.
2019 Dec;71(12):1971-1973.
doi: 10.1002/art.41064.
Epub 2019 Oct 23.
Authors
Lenore M Buckley
1
,
Maria E Suarez-Almazor
2
Affiliations
1
Yale University School of Medicine, New Haven, Connecticut.
2
University of Texas MD Anderson Cancer Center, Houston.
PMID:
31379056
DOI:
10.1002/art.41064
No abstract available
Publication types
Editorial
Comment
MeSH terms
Autoimmune Diseases*
Cohort Studies
Humans
Neoplasms*
Rheumatic Diseases*